Department of Rheumatology, 1st Affiliated Hospital of China Medical University, Shenyang 110001, PR China; Department of Rheumatology, 2nd Affiliated Hospital of Dalian Medical University, Dalian 116021, PR China.
Cytokine. 2013 Oct;64(1):22-4. doi: 10.1016/j.cyto.2013.07.006. Epub 2013 Jul 31.
To determine whether interleukin (IL)-33 and soluble ST2 (sST2) are associated with primary Sjogren's Syndrome (pSS).
Serum levels of IL-33 and sST2 in 110 pSS patients and 78 healthy controls were measured by enzyme-linked immunosorbent assay (ELISA). Immunoglobulins, rheumatoid factors (RF), antinuclear antibody (ANA), anti-SSA/RO-52 antibody, anti-SSB antibody and erythrocyte sedimentation rate (ESR) were measured by standard laboratory techniques. Interstitial lung disease (ILD) was identified on high-resolution computed tomography (HRCT). Disease activity in pSS was scored with the European League Against Rheumatism Sjogren's Syndrome Disease Activity Index (ESSDAI).
Serum levels of IL-33 and sST2 were significantly elevated in pSS patients, especially in patients with ILD. There was significant positive correlation between IL-33 and RF, anti-SSB antibody.
IL-33/sST2 may be involved in the pathogenesis of pSS and partly contribute to the ILD in pSS patients.
探讨白细胞介素(IL)-33 和可溶性 ST2(sST2)与原发性干燥综合征(pSS)的相关性。
采用酶联免疫吸附试验(ELISA)检测 110 例 pSS 患者和 78 名健康对照者血清中 IL-33 和 sST2 的水平。采用标准实验室技术检测免疫球蛋白、类风湿因子(RF)、抗核抗体(ANA)、抗 SSA/RO-52 抗体、抗 SSB 抗体和红细胞沉降率(ESR)。采用高分辨率计算机断层扫描(HRCT)诊断间质性肺疾病(ILD)。采用欧洲抗风湿病联盟干燥综合征疾病活动指数(ESSDAI)对 pSS 患者的疾病活动进行评分。
pSS 患者血清中 IL-33 和 sST2 水平显著升高,尤其是在伴有ILD 的患者中。IL-33 与 RF、抗 SSB 抗体呈显著正相关。
IL-33/sST2 可能参与 pSS 的发病机制,并部分导致 pSS 患者发生 ILD。